Biomarkers are a big deal in the clinical world: if as a doctor you’re able to take one simple measurement that allows you to look into a patient’s fu...
What’s new in media and industry: Laura Deming’s intro to longevity, and more
Just getting started around here, or want to introduce someone new to the world of longevity science? This handy primer from Laura Deming (of Longevit...
Are cancer prevention and cellular reprogramming really enemies?
Imagine a physiological love triangle: in one corner, a force with the weight of millions of years of evolutionary programming trained on preventing r...
Research roundup: The microbiome in neurodegenerative disease, and more
It’s looking increasingly likely that our little bacterial buddies have a major influence on neurodegenerative disease, from producing extra amy...
Can reducing PPAR-γ save the immune system?
One contributor to the aging of your immune system is that your thymus–the gland that turns leukocytes into T cells–is slowly replaced by ...
Merry Media, And A Happy New Year
We want you! Reason over at Fight Aging! lists nine promising approaches to rejuvenation therapy that he’d like to see in the very near future: ...
A peek inside the companies using AI to combat aging
Last Wednesday I attended the Buck Institute’s workshop on AI and Longevity, where speakers from several different organizations discussed how t...
Oxidative stress response: One of the many jobs of tumor-suppressor p53
At its most dramatic, oxidative stress can rend DNA in two and predispose cells to mutations that ultimately result in cancer. But the less bombastic ...
Research roundup: The importance of energy in Alzheimer’s, and more
Since the world of Alzheimer’s therapeutics hasn’t seen much practical benefit from targeting harmful proteins like amyloid-beta, maybe ot...
In the media: An AMA with Aubrey de Grey, and more
Aubrey de Grey held a Reddit AMA on December 7th, discussing everything from AI in longevity research, CR mimetics, and how his timelines for therapeu...